Bristol-Myers, Astra Diabetes Drug Gets FDA Nod

Bristol-Myers Squibb Co and AstraZeneca Plc said U.S. health regulators have approved a once-a-day pill that combines two medicines for the treatment of Type 2 diabetes in adults.
London South East